Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hauser AK"" wg kryterium: Autor


Tytuł :
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD GBA .
Autorzy :
Lerche S; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Schulte C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Wurster I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Machetanz G; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Roeben B; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Zimmermann M; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Deuschle C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Hauser AK; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Böhringer J; Children's Hospital, University of Tübingen, Tübingen, Germany.
Krägeloh-Mann I; Children's Hospital, University of Tübingen, Tübingen, Germany.
Waniek K; Roboscreen GmbH, Leipzig, Germany.
Lachmann I; Roboscreen GmbH, Leipzig, Germany.
Petterson XT; Department of Health Sciences Research and Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Chiang R; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Cambridge, Massachusetts, USA.
Park H; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Cambridge, Massachusetts, USA.
Wang B; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Cambridge, Massachusetts, USA.
Liepelt-Scarfone I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Maetzler W; Department of Neurology, Christian-Albrechts University, Kiel, Germany.
Galasko D; Department of Neurology, University of California at San Diego, San Diego, California, USA.
Scherzer CR; Center for Advanced Parkinson Research, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Gasser T; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Mielke MM; Department of Health Sciences Research and Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Hutten SJ; Michel J. Fox Foundation for Parkinson's Research (MJFF), New York, New York, USA.
Mollenhauer B; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; Paracelsus-Elena Klinik Kassel, Kassel, Germany.; Department of Neurology, University Medical Center Goettingen, Göttingen, Germany.
Sardi SP; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Cambridge, Massachusetts, USA.
Berg D; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; Department of Neurology, Christian-Albrechts University, Kiel, Germany.
Brockmann K; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, University of Tübingen, Tuebingen, Germany.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2021 May; Vol. 36 (5), pp. 1216-1228. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Parkinson Disease*/genetics
alpha-Synuclein*/genetics
Glucosylceramidase/genetics ; Humans ; Mutation/genetics ; Sphingolipids
Czasopismo naukowe
Tytuł :
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease.
Autorzy :
Zimmermann M; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Köhler L; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
Kovarova M; Department of Internal Medicine, University of Tuebingen, Tuebingen, Germany.
Lerche S; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Schulte C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Wurster I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Machetanz G; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Deuschle C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Hauser AK; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Gasser T; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Berg D; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Schleicher E; Department of Internal Medicine, University of Tuebingen, Tuebingen, Germany.
Maetzler W; Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Brockmann K; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE, University of Tuebingen, Tuebingen, Germany.
Pokaż więcej
Źródło :
European journal of neurology [Eur J Neurol] 2021 May; Vol. 28 (5), pp. 1557-1565. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Novel SNCA A30G Mutation Causes Familial Parkinson's Disease.
Autorzy :
Liu H; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen and German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Koros C; 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; 2nd Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Strohäker T; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Schulte C; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen and German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Bozi M; 2nd Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Varvaresos S; 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Ibáñez de Opakua A; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Simitsi AM; 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Bougea A; 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Voumvourakis K; 2nd Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Maniati M; Laboratory of Neurodegenerative Diseases, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Papageorgiou SG; 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; 2nd Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Hauser AK; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen and German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Becker S; Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Zweckstetter M; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.; Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Stefanis L; 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Laboratory of Neurodegenerative Diseases, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Gasser T; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen and German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2021 Feb 22. Date of Electronic Publication: 2021 Feb 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Phenylalanine Effects on Brain Function in Adult Phenylketonuria.
Autorzy :
Pilotto A; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands. .
Zipser CM; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Leks E; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Haas D; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Gramer G; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Freisinger P; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Schaeffer E; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Liepelt-Scarfone I; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Brockmann K; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Maetzler W; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Schulte C; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Deuschle C; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Hauser AK; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Hoffmann GF; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Scheffler K; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
van Spronsen FJ; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Padovani A; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Trefz F; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Berg D; From the Neurology Unit (A. Pilotto, A. Padovani), Department of Clinical and Experimental Sciences, University of Brescia, Italy; Department of Neurodegeneration (A. Pilotto, I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Hertie Institute of Clinical Brain Research (A. Pilotto, C.M.Z., I.L.-S., K.B., W.M., C.S., C.D., A.K.H., D.B.), Department of Neurology and Stroke (C.M.Z.), Department of Biomedical Magnetic Resonance (E.L., K.S.), and German Center for Neurodegenerative Diseases (I.L.-S., K.B., C.S., C.D., A.K.H., K.S.), University of Tübingen, Germany; Parkinson's Disease Rehabilitation Centre (A. Pilotto), FERB ONLUS, S. Isidoro Hospital, Trescore Balneario, Italy; Department of Pediatrics (D.H., G.G., G.F.H., F.T.), Division for Neuropediatrics and Metabolic Medicine, University of Heidelberg; Department of Pediatrics (P.F., F.T.), Reutlingen Hospital; Department of Neurology (E.S., W.M., D.B.), University-Hospital-Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University Kiel; and Division of Metabolic Diseases (F.J.v.S.), Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, the Netherlands.
Pokaż więcej
Źródło :
Neurology [Neurology] 2021 Jan 19; Vol. 96 (3), pp. e399-e411. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cognition/*physiology
Phenylalanine/*blood
Phenylketonurias/*blood
Putamen/*diagnostic imaging
Thalamus/*diagnostic imaging
Adult ; Atrophy/blood ; Atrophy/diagnostic imaging ; Atrophy/psychology ; Cross-Sectional Studies ; Evoked Potentials, Motor/physiology ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Neuropsychological Tests ; Phenylketonurias/diagnostic imaging ; Phenylketonurias/psychology ; Prospective Studies
Czasopismo naukowe
Tytuł :
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles.
Autorzy :
Lerche S; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Wurster I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Roeben B; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Zimmermann M; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Riebenbauer B; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Deuschle C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Hauser AK; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Schulte C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Berg D; Department of Neurology, Christian-Albrechts University, Kiel, Germany.
Maetzler W; Department of Neurology, Christian-Albrechts University, Kiel, Germany.
Waniek K; AJ Roboscreen GmbH, Leipzig, Germany.
Lachmann I; AJ Roboscreen GmbH, Leipzig, Germany.
Liepelt-Scarfone I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Gasser T; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Brockmann K; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2020 Mar; Vol. 35 (3), pp. 495-499. Date of Electronic Publication: 2019 Oct 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Glucosylceramidase*/genetics
Parkinson Disease*/genetics
Humans ; Lewy Bodies ; Mutation/genetics ; alpha-Synuclein/genetics
Czasopismo naukowe
Tytuł :
Do longitudinal cerebrospinal fluid profiles correspond to postmortem brain pathology in LRRK2 Parkinson's disease?
Autorzy :
Wurster I; Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, Tuebingen, Germany.
Lerche S; Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, Tuebingen, Germany.
Hauser AK; German Center for Neurodegenerative Diseases, Tuebingen, Germany.
Schulte C; Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
Lachmann I; AJ Roboscreen GmbH, Leipzig, Germany.
Beschorner R; Department of Neuropathology, University of Tuebingen, Tuebingen, Germany.
Neumann M; German Center for Neurodegenerative Diseases, Tuebingen, Germany.; Department of Neuropathology, University of Tuebingen, Tuebingen, Germany.
Brockmann K; Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, Tuebingen, Germany.
Pokaż więcej
Źródło :
European journal of neurology [Eur J Neurol] 2020 Jan; Vol. 27 (1), pp. e5-e6. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
Raport
Tytuł :
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.
Autorzy :
Lerche S; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Machetanz G; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Wurster I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Roeben B; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Zimmermann M; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Pilotto A; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; Parkinson's Disease Rehabilitation Centre, FERB ONLUS-S. Isidoro Hospital, Trescore Balneario (BG), Italy.
Preische O; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
Stransky E; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
Deuschle C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Hauser AK; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Schulte C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Lachmann I; AJ Roboscreen GmbH, Leipzig, Germany.
Waniek K; AJ Roboscreen GmbH, Leipzig, Germany.
Gasser T; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Berg D; Department of Neurology, Christian-Albrechts University, Kiel, Germany.
Maetzler W; Department of Neurology, Christian-Albrechts University, Kiel, Germany.
Brockmann K; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2019 Jul; Vol. 34 (7), pp. 1069-1073. Date of Electronic Publication: 2019 Jun 12.
Typ publikacji :
Journal Article
MeSH Terms :
Glucosylceramidase/*genetics
Lewy Body Disease/*genetics
Mutation/*genetics
alpha-Synuclein/*cerebrospinal fluid
Aged ; Alzheimer Disease/cerebrospinal fluid ; Amyloid beta-Peptides/cerebrospinal fluid ; Biomarkers/cerebrospinal fluid ; Female ; Gene Expression/genetics ; Humans ; Lewy Bodies/metabolism ; Lewy Body Disease/diagnosis ; Male ; Middle Aged ; alpha-Synuclein/genetics ; tau Proteins/cerebrospinal fluid
Czasopismo naukowe
Tytuł :
Patient's perception: shorter and more severe prodromal phase in GBA-associated PD.
Autorzy :
Zimmermann M; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Gaenslen A; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Prahl K; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
Srulijes K; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Hauser AK; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Schulte C; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Csoti I; Gertrudis Klinik, Leun-Biskirchen, Germany.
Berg D; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Brockmann K; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Pokaż więcej
Źródło :
European journal of neurology [Eur J Neurol] 2019 Apr; Vol. 26 (4), pp. 694-698. Date of Electronic Publication: 2018 Sep 14.
Typ publikacji :
Journal Article
MeSH Terms :
Mutation*
Prodromal Symptoms*
Glucosylceramidase/*genetics
Parkinson Disease/*genetics
Aged ; Female ; Heterozygote ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Time Factors
Czasopismo naukowe
Tytuł :
Cholinergic Pathway SNPs and Postural Control in 477 Older Adults.
Autorzy :
Arnold C; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Schulte C; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Moscovich M; Department of Neurology, University of Kiel, Kiel, Germany.
Sünkel U; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Zaunbrecher L; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Metzger F; Geriatric Center at the University Hospital of Tübingen, Tübingen, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.
Gasser T; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Eschweiler GW; Geriatric Center at the University Hospital of Tübingen, Tübingen, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany.
Hauser AK; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Berg D; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.; Department of Neurology, University of Kiel, Kiel, Germany.
Maetzler W; Department of Neurodegenerative Diseases, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases, Tübingen, Germany.; Department of Neurology, University of Kiel, Kiel, Germany.
Pokaż więcej
Źródło :
Frontiers in aging neuroscience [Front Aging Neurosci] 2018 Sep 04; Vol. 10, pp. 260. Date of Electronic Publication: 2018 Sep 04 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
HPCA confirmed as a genetic cause of DYT2-like dystonia phenotype.
Autorzy :
Atasu B; German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Hanagasi H; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Bilgic B; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Pak M; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Erginel-Unaltuna N; Aziz Sancar Institute for Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey.
Hauser AK; German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Guven G; Aziz Sancar Institute for Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey.
Simón-Sánchez J; German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Heutink P; German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Gasser T; German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Lohmann E; German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2018 Aug; Vol. 33 (8), pp. 1354-1358. Date of Electronic Publication: 2018 Aug 25.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Dystonia/*genetics
Hippocalcin/*genetics
Mutation/*genetics
Consanguinity ; DNA Mutational Analysis ; Dystonia/diagnosis ; Family Health ; Female ; Humans ; Male ; Phenotype ; Turkey ; Young Adult
Czasopismo naukowe
Tytuł :
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.
Autorzy :
Lerche S; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Liepelt-Scarfone I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Wurster I; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Schulte C; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Schäffer E; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; Department of Neurology, Christian-Albrechts-University, Kiel, Germany.
Röben B; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Machetanz G; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Zimmermann M; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Akbas S; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Hauser AK; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Gasser T; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Maetzler W; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; Department of Neurology, Christian-Albrechts-University, Kiel, Germany.
Berg D; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; Department of Neurology, Christian-Albrechts-University, Kiel, Germany.
Brockmann K; Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.; German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2018 Aug; Vol. 33 (8), pp. 1349-1353. Date of Electronic Publication: 2018 Aug 22.
Typ publikacji :
Journal Article
MeSH Terms :
Genetic Predisposition to Disease/*genetics
Multifactorial Inheritance/*genetics
Parkinson Disease/*genetics
Parkinson Disease/*physiopathology
Adult ; Age of Onset ; Aged ; Aged, 80 and over ; Disease Progression ; Female ; Genome-Wide Association Study ; Humans ; Longitudinal Studies ; Male ; Mental Status and Dementia Tests ; Middle Aged ; Phenotype
Czasopismo naukowe
Tytuł :
Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
Autorzy :
Kessler C; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Atasu B; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Hanagasi H; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Simón-Sánchez J; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Hauser AK; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Pak M; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Bilgic B; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Erginel-Unaltuna N; Institute for Experimental Medical Research, Istanbul University, Turkey.
Gurvit H; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Gasser T; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Lohmann E; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Electronic address: .
Pokaż więcej
Źródło :
Parkinsonism & related disorders [Parkinsonism Relat Disord] 2018 Mar; Vol. 48, pp. 34-39. Date of Electronic Publication: 2017 Dec 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/*genetics
Parkinson Disease/*genetics
Point Mutation/*genetics
alpha-Synuclein/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Genetic Testing ; Humans ; Male ; Middle Aged ; Turkey ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies